Results 191 to 200 of about 219,094 (347)

Label‐Free Photonic Biosensors: Key Technologies for Precision Diagnostics

ChemistryEurope, EarlyView.
Photonic biosensors are versatile technologies promising unique advantages to improve current diagnosis workflows. On‐going research is directed to systems integration and automation as well as enhancing assay performance. Advances in bioengineering, material sciences, and photonics engineering will be the key toward their eventual implementation as ...
Maria Soler, Laura M. Lechuga
wiley   +1 more source

AUTOANTIBODIES TO COLON IN GERMFREE RATS MONOCONTAMINATED WITH CLOSTRIDIUM DIFFICILE [PDF]

, 1969
Sten Hammarström, Peter Perlmann, Bengt E. Gustafsson, R Lagercrantz   +3 more
openalex   +1 more source

The National Academies’ 2024 Diagnostic Criteria for Long COVID: Concerns That Could Affect the Rheumatology Community

Arthritis &Rheumatology, EarlyView.
Leonard H. Calabrese, Michael Putman, Jeffrey A. Sparks, Zachary Wallace, Alfred H. J. Kim, Kevin L. Winthrop, Cassandra Calabrese   +6 more
wiley   +1 more source

Salivary and plasmatic levels of tumor necrosis factor‐alpha do not correlate with the clinicopathological profile in breast cancer patients

Precision Medical Sciences, Volume 11, Issue 4, Page 155-160, December 2022., 2022
Tumor necrosis factor (TNF) levels in saliva and plasma samples from patients diagnosed with breast cancer do not correlate with clinicopathological features that are indicative of disease prognosis. Abstract Herein, we evaluated the salivary and plasmatic levels of tumor necrosis factor‐alpha (TNF‐α) in women diagnosed with breast cancer (BC; n = 20 ...
Marcelo Marcos Opolski, Vitor Teixeira Maito, Aedra Carla Bufalo Kawassaki, Janaína Carla da Silva, Rodrigo Kern, Daniel Rech, Stefania Tagliari de Oliveira, Pâmela Lonardoni Micheletti, Carolina Panis, Sabrina Grassiolli   +9 more
wiley   +1 more source

Antibodies and Autoantibodies of Glycogen Phosphorylase b: Inactivation of Pig and Rabbit Enzymes [PDF]

, 1977
Socrates J. Tzartos, Athanasios E. Evangelopoulos   +1 more
openalex   +1 more source

Cardiac myosin binding protein C correlate with cardiac troponin I during an exercise training program in patients with HFrEF

ESC Heart Failure, EarlyView.
Abstract Background Cardiac myosin binding protein C (cMyC) is an emerging new biomarker of myocardial injury rising earlier and cleared faster than cardiac troponins. It has discriminatory power similar to high‐sensitive troponins in diagnosing myocardial infarction in patients presenting with chest pain. It is also associated with outcome in patients
E. Riveland, A. Ushakova, T. Valborgland, T. Karlsen, H. Dalen, E. Prescott, T. Omland, A. Linke, M. Halle, M. Marber, Ø. Ellingsen, A.I. Larsen, on behalf of the SMARTEX‐HF Study Group   +12 more
wiley   +1 more source

Classification of smooth muscle autoantibodies detected by immunofluorescence. [PDF]

, 1976
G. F. Bottazzo, A Florin-Christensen, A J Fairfax, G T Swana, Deborah Doniach, U Groeschel-Stewart   +5 more
openalex   +1 more source

Immune cell dynamics in heart failure: implicated mechanisms and therapeutic targets

ESC Heart Failure, EarlyView.
Abstract The relationship between heart failure (HF) and immune activation has garnered significant interest. Studies highlight the critical role of inflammation in HF, affecting cardiac structure and function. Despite promising anti‐inflammatory therapies, clinical trials have faced challenges, indicating an incomplete understanding of immune ...
Gen Li, Wu He, Dao Wen Wang
wiley   +1 more source

AGE INFLUENCED CATTLE SERUM ANTIGEN DETECTED BY AUTOANTIBODIES [PDF]

, 1974
D. IANNELLI, P. MASINA, T. M. BETTINI
openalex   +1 more source

Immune Checkpoint Inhibitors and Cardiovascular Adverse Events

ESC Heart Failure, EarlyView.
Abstract In the last years, we assisted to a tremendous increase in therapeutic options for the management of cancers, with immunotherapy at the forefront of this innovation. Immune checkpoint inhibitors (ICIs) have been developed to enhance the activity of the immune system against cancer cells (1) and the number of approvals for ICIs has rapidly ...
Maria Luisa De Perna, Elia Rigamonti, Raffaele Zannoni, Vittoria Espeli, Giorgio Moschovitis   +4 more
wiley   +1 more source